Phenotype characterization of human melanoma cells resistant to Dabrafenib

Autor: Cordaro FG, De Presbiteris AL, Camerlingo R, Miceli R, Fratangelo F, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Patriarca EJ, Ciliberto E, Ascierto PA, Caputo E

Publikováno v: Oncology Reports (Online) (2016).
info:cnr-pdr/source/autori:Cordaro FG, De Presbiteris AL, Camerlingo R, Miceli R, Fratangelo F, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Patriarca EJ, Ciliberto E, Ascierto PA, Caputo E/titolo:Phenotype characterization of human melanoma cells resistant to Dabrafenib/doi:/rivista:Oncology Reports (Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume

Combined B-RAF and MEK inhibition elicits rapid anti-tumor responses in the most patients with B-RAF (V600E) mutant metastatic melanoma. However, combined treatment is not a sufficient strategy to overcome drug resistance development. We selected in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::0952ca4336f6721cea616e55bdfee4ce
https://publications.cnr.it/doc/361230

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis.

Autor: E P; San Giovanni di Dio Hospital, Florence, Italy., M S; Department of Biomedical Sciences and Human Oncology, University 'Aldo Moro' of Bari.. Electronic address: marta.simone@uniba.it., E P; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., A B; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., L P; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., M N; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy., L R; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., R F; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., L T; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., M F; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., A G; MS Centre, Hospital of Gallarate, Italy., L P; MS Centre, Hospital of Gallarate, Italy., Mg M; MS Centre, Binaghi Hospital, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy., E C; MS Centre, Binaghi Hospital, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy., G F; MS Centre, Binaghi Hospital, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy., F P; Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Italy., C C; Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Italy., M F; IRCCS Hospital San Raffaele, Milan, Italy., L M; IRCCS Hospital San Raffaele, Milan, Italy., E M; IRCCS Hospital San Raffaele, Milan, Italy., Rg V; Department of Basic Medical Sciences, Neuroscience and Sense Organs. University ' Aldo Moro' of Bari, Italy., L M; Department of Biomedical Sciences and Human Oncology, University 'Aldo Moro' of Bari., B G; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., Mp A; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jul; Vol. 42, pp. 102145. Date of Electronic Publication: 2020 May 04.